James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 5,173 shares at $34.09 ($176K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $176k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.09 | 835 | $28K | 16.1% |
| 2 | $34.09 | 2,169 | $74K | 41.9% |
| 3 | $34.09 | 2,169 | $74K | 41.9% |
| Total | $34.09 avg | 5,173 | $176K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |